You have 9 free searches left this month | for more free features.

177lu-psma-617

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Mar 1, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (177Lu-PSMA-617, PSMA-11)

No longer available
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 12, 2023

Prostate Cancer Trial in New York (177Lu-PSMA-617, Stereotactic Body Radiotherapy (SBRT))

Active, not recruiting
  • Prostate Cancer
  • 177Lu-PSMA-617
  • Stereotactic Body Radiotherapy (SBRT)
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 17, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Melbourne (Cabazitaxel, 177Lu-PSMA-617)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • mCRPC
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Jul 20, 2022

Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)

Recruiting
  • Metastatic Hormone Naive Prostate Cancer
  • Sydney, New South Wales, Australia
  • +4 more
Nov 4, 2022

Prostate Cancer Trial in New Orleans, New York (177Lu-PSMA-617, 68Ga-PSMA-HBED-CC)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +1 more
Nov 20, 2021

Prostate Cancer Trial in New York (177Lu-PSMA-617, 177Lu-J591, 68Ga-PSMA-HBED-CC)

Terminated
  • Prostate Cancer
  • 177Lu-PSMA-617
  • +2 more
  • New York, New York
    Weill Cornell Medical College
Jul 29, 2021

Prostate Cancer Trial in Vancouver, Montreal, Quebec City (177Lu-PSMA-617, Docetaxel)

Suspended
  • Prostate Cancer
  • Vancouver, British Columbia, Canada
  • +3 more
Jun 13, 2022

Prostate Cancer Trial in Amsterdam, Groningen, Nijmegen (177Lu-PSMA-617)

Recruiting
  • Prostate Cancer
  • 177Lu-PSMA-617
  • Amsterdam, Netherlands
  • +3 more
Oct 17, 2021

Prostatic Tumor Trial in Amsterdam, Utrecht (177Lu-PSMA-617, EBRT)

Recruiting
  • Prostatic Neoplasm
  • 177Lu-PSMA-617
  • EBRT
  • Amsterdam, Netherlands
  • +1 more
Dec 21, 2021

Metastatic Castration Resistant Prostate Cancer Trial in Los Angeles, Houston (177Lu-PSMA-617)

Terminated
  • Metastatic Castration Resistant Prostate Cancer
  • 177Lu-PSMA-617
  • Los Angeles, California
  • +1 more
Mar 1, 2021